Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels.

Source:http://linkedlifedata.com/resource/pubmed/id/10870480

Download in:

View as

General Info

PMID
10870480